Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice

Ann Hematol. 2017 Sep;96(9):1591-1593. doi: 10.1007/s00277-017-3064-0. Epub 2017 Jul 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Disease Management
  • Female
  • Follow-Up Studies
  • Frail Elderly
  • Humans
  • Leukemia, Myelomonocytic, Chronic / drug therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine